Literature DB >> 11390981

Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.

B T Kim1, H Kitagawa, J Tamura , T Saito, M Kusche-Gullberg, U Lindahl, K Sugahara.   

Abstract

The tumor suppressors EXT1 and EXT2 are associated with hereditary multiple exostoses and encode bifunctional glycosyltransferases essential for chain polymerization of heparan sulfate (HS) and its analog, heparin (Hep). Three highly homologous EXT-like genes, EXTL1-EXTL3, have been cloned, and EXTL2 is an alpha1,4-GlcNAc transferase I, the key enzyme that initiates the HS/Hep synthesis. In the present study, truncated forms of EXTL1 and EXTL3, lacking the putative NH2-terminal transmembrane and cytoplasmic domains, were transiently expressed in COS-1 cells and found to harbor alpha-GlcNAc transferase activity. EXTL3 used not only N-acetylheparosan oligosaccharides that represent growing HS chains but also GlcAbeta1-3Galbeta1-O-C2H4NH-benzyloxycarbonyl (Cbz), a synthetic substrate for alpha-GlcNAc transferase I that determines and initiates HS/Hep synthesis. In contrast, EXTL1 used only the former acceptor. Neither EXTL1 nor EXTL3 showed any glucuronyltransferase activity as examined with N-acetylheparosan oligosaccharides. Heparitinase I digestion of each transferase-reaction product showed that GlcNAc had been transferred exclusively through an alpha1,4-configuration. Hence, EXTL3 most likely is involved in both chain initiation and elongation, whereas EXTL1 possibly is involved only in the chain elongation of HS and, maybe, Hep as well. Thus, their acceptor specificities of the five family members are overlapping but distinct from each other, except for EXT1 and EXT2 with the same specificity. It now has been clarified that all of the five cloned human EXT gene family proteins harbor glycosyltransferase activities, which probably contribute to the synthesis of HS and Hep.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390981      PMCID: PMC34642          DOI: 10.1073/pnas.131188498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Specificities of heparan sulphate proteoglycans in developmental processes.

Authors:  N Perrimon; M Bernfield
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.

Authors:  S Kobayashi; K Morimoto; T Shimizu; M Takahashi; H Kurosawa; T Shirasawa
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

3.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 4.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

5.  HEREDITARY MULTIPLE EXOSTOSIS.

Authors:  L SOLOMON
Journal:  Am J Hum Genet       Date:  1964-09       Impact factor: 11.025

6.  Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo.

Authors:  H Toyoda; A Kinoshita-Toyoda; S B Selleck
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

7.  Refined physical mapping and genomic structure of the EXTL1 gene.

Authors:  W Wuyts; N Spieker; N Van Roy; K De Boulle; A De Paepe; P J Willems; W Van Hul; R Versteeg; F Speleman
Journal:  Cytogenet Cell Genet       Date:  1999

8.  EXTL3/EXTR1 alterations in colorectal cancer cell lines.

Authors:  T Arai; Y Akiyama; H Nagasaki; N Murase; S Okabe; T Ikeuchi; K Saito; T Iwai; Y Yuasa
Journal:  Int J Oncol       Date:  1999-11       Impact factor: 5.650

Review 9.  Heparan sulfate: a piece of information.

Authors:  M Salmivirta; K Lidholt; U Lindahl
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

Review 10.  The elusive functions of proteoglycans: in vivo veritas.

Authors:  A D Lander; S B Selleck
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

View more
  45 in total

Review 1.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Authors:  G Duncan; C McCormick; F Tufaro
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Authors:  Beverly M Zak; Manuela Schuksz; Eiki Koyama; Christina Mundy; Dan E Wells; Yu Yamaguchi; Maurizio Pacifici; Jeffrey D Esko
Journal:  Bone       Date:  2011-02-15       Impact factor: 4.398

3.  Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.

Authors:  Satomi Nadanaka; Eko Purunomo; Naoko Takeda; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

4.  Age modulates liver responses to asparaginase-induced amino acid stress in mice.

Authors:  Inna A Nikonorova; Qiaoqiao Zhu; Christina C Signore; Emily T Mirek; William O Jonsson; Bo Kong; Grace L Guo; William J Belden; Tracy G Anthony
Journal:  J Biol Chem       Date:  2019-08-14       Impact factor: 5.157

Review 5.  Reg3 Proteins as Gut Hormones?

Authors:  Jae Hoon Shin; Randy J Seeley
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

6.  Reduced Expression of EXTL2, a Member of the Exostosin (EXT) Family of Glycosyltransferases, in Human Embryonic Kidney 293 Cells Results in Longer Heparan Sulfate Chains.

Authors:  Kirankumar Katta; Tabasum Imran; Marta Busse-Wicher; Mona Grønning; Szymon Czajkowski; Marion Kusche-Gullberg
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

Review 7.  The nematode Caenorhabditis elegans as a model to study the roles of proteoglycans.

Authors:  Patricia M Berninsone; Carlos B Hirschberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.

Authors:  Meirav Trebicz-Geffen; Dror Robinson; Zoharia Evron; Tova Glaser; Mati Fridkin; Yehuda Kollander; Israel Vlodavsky; Neta Ilan; Kit Fong Law; Kathryn S E Cheah; Danny Chan; Haim Werner; Zvi Nevo
Journal:  Int J Exp Pathol       Date:  2008-04-30       Impact factor: 1.925

Review 9.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

10.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.